The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2016-10, Vol.51 (10), p.1404-1407
Hauptverfasser:	Montesinos, P, Cabrero, M, Valcárcel, D, Rovira, M, García-Marco, J A, Loscertales, J, Moreno, C, Duarte, R, Terol, M J, Villamor, N, Abrisqueta, P, Caballero, D, Sanz, J, Delgado, J
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 692/308/153 692/308/2779/109/1940 Analysis Bone marrow Care and treatment Cell Biology Chronic lymphocytic leukemia Dosage and administration Hematology Internal Medicine letter-to-the-editor Medicine Medicine & Public Health Ofatumumab Public Health Stem cell transplantation Stem Cells Transplantation Treatment outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!